Waters Stock (NYSE:WAT)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$323.44

52W Range

$279.24 - $423.56

50D Avg

$368.29

200D Avg

$357.27

Market Cap

$19.10B

Avg Vol (3M)

$532.67K

Beta

1.04

Div Yield

-

WAT Company Profile


Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

7,600

IPO Date

Nov 17, 1995

Website

WAT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24Dec 23Dec 22
Waters Instrument Systems$1.03B$1.11B$1.21B
Chemistry Consumables$565.48M$541.47M-
Ta Instrument Systems$246.20M$252.88M$252.31M
Ta Service$107.76M$101.95M$93.18M
Waters Service$1.01B$951.42M$890.61M
Service-$1.05B-
Product-$1.90B$1.99B

Fiscal year ends in Dec 24 | Currency in USD

WAT Financial Summary


Dec 24Dec 23Dec 22
Revenue$2.96B$2.96B$2.97B
Operating Income$826.35M$817.68M$873.39M
Net Income$637.83M$642.23M$707.75M
EBITDA$826.35M$1.00B$1.01B
Basic EPS$10.75$10.87$11.80
Diluted EPS$10.71$10.84$11.73

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q4 24Feb 12, 25 | 8:00 AM
Q3 24Nov 01, 24 | 8:00 AM
Q2 24Jul 31, 24 | 8:00 AM

Peer Comparison


TickerCompany
TWSTTwist Bioscience Corporation
MTDMettler-Toledo International Inc.
DHRDanaher Corporation
ICLRICON Public Limited Company
IQVIQVIA Holdings Inc.
TMOThermo Fisher Scientific Inc.
RVTYRevvity, Inc.
IDXXIDEXX Laboratories, Inc.
CRLCharles River Laboratories International, Inc.
ILMNIllumina, Inc.
SHCSotera Health Company